Cover Image

Predictors of residual tumor in breast-conserving therapy

Breast-conserving therapy is considered to be the standard treatment for early breast tumors (T1-T2). In up to 82 % of breast-conserving surgery, tumor cells were still found to be present at or near the cut edge of the surgical specimen after surgery. Thus, it is of clinical need to identify tumors...

Full description

Saved in:
Bibliographic Details
Main Authors: Rath, Michèlle Geneviève (Author) , Uhlmann, Lorenz (Author) , Heil, Jörg (Author) , Domschke, Christoph (Author) , Roth, Zdravka (Author) , Sinn, Peter (Author) , Marmé, Frederik (Author) , Scharf, Alexander (Author) , Schneeweiss, Andreas (Author) , Kieser, Meinhard (Author) , Sohn, Christof (Author) , Rom, Joachim (Author)
Format: Article (Journal)
Language:English
Published: 30 July 2015
In: Annals of surgical oncology
Year: 2015, Volume: 22, Issue: 3, Pages: 451-458
ISSN:1534-4681
DOI:10.1245/s10434-015-4736-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-015-4736-4
Get full text
Author Notes:Michelle G. Rath, Lorenz Uhlmann, Joerg Heil, Christoph Domschke, Zdravka Roth, Hans-Peter Sinn, Frederik Marme, Alexander Scharf, Andreas Schneeweiss, Meinhard Kieser, Christof Sohn, and Joachim Rom
Description
Summary:Breast-conserving therapy is considered to be the standard treatment for early breast tumors (T1-T2). In up to 82 % of breast-conserving surgery, tumor cells were still found to be present at or near the cut edge of the surgical specimen after surgery. Thus, it is of clinical need to identify tumors at high probability for reexcision in the preoperative setting.
Item Description:Gesehen am 10.06.2020
Physical Description:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-015-4736-4

Similar Items